摘 要 目的：探讨液基薄层细胞学检测(TCT)和高危型人乳头瘤状病毒DNA(HR-HPV DNA)检测对宫颈病变筛查的价值，为政府制定疫苗的预防政策提供理论依据。方法：选取在我院就诊或体检的妇女243例，均行TCT、HR-HPV DNA检测，分析其检测结果。结果：TCT+HR-HPV DNA联合检测的特异性、阳性预测值和诊断符合率均明显高于HR-HPV DNA单项检测，差异具有统计学意义(P<0.05)。结论：TCT 和HR-HPV DNA联合检测可提高宫颈病变及早期宫颈癌的诊断水平，降低漏诊率，对宫颈病变的早期筛查具有重要意义。

    关键词 液基薄层细胞学检测 人乳头瘤状病毒 宫颈病变

    中图分类号：R730.43； R737.33 文献标识码：B 文章编号：1006-1533(2015)03-0046-03

    ABSTRACT Objective： To investigate the value of thinprep cytology test (TCT) and high-risk human papilloma virus DNA (HR-HPV DNA) detection in the screening of cervical lesions so as to provide a theoretical basis for the government to formulate the vaccine prevention policy. Methods： Two hundred and forty-three women diagnosed or examined in our hospital were selected ......